ImmuQuad Biotechnologies

ImmuQuad Biotechnologies is a private China-based immunogenomics company focused on decoding the adaptive immune system for disease diagnosis, monitoring, and therapy development. The company offers TCR/BCR sequencing-based products and services including ImmuHub for immune repertoire analysis, Seq-MRD for measurable residual disease detection in blood cancers, Immun-Traq for treatment monitoring, Immun-Cheq for immune evaluation, and T-Classifier for AI-enabled early disease screening. ImmuQuad also uses single-cell and antigen-specific TCR discovery workflows to support TCR-T drug discovery and personalized immunotherapy development. Its business spans clinical diagnostics, research services, and enabling technologies for biopharma and hospital partners, with a focus on cancer as well as other immune-mediated diseases.